BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1345 related articles for article (PubMed ID: 28848338)

  • 1. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
    Calle Rubio M; Casamor R; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: "the ESPIRAL-ES study".
    Alcázar-Navarrete B; Trigueros JA; Riesco JA; Campuzano A; Pérez J
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1115-1124. PubMed ID: 29692606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of chronic bronchitic, emphysematous and ACOS phenotypes in COPD patients with frequent exacerbations.
    Cheng Y; Tu X; Pan L; Lu S; Xing M; Li L; Chen X
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2069-2074. PubMed ID: 28790809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical phenotypes of COPD and health-related quality of life: a cross-sectional study.
    Chai CS; Liam CK; Pang YK; Ng DL; Tan SB; Wong TS; Sia JE
    Int J Chron Obstruct Pulmon Dis; 2019; 14():565-573. PubMed ID: 30880946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The characteristics of the frequent exacerbator with chronic bronchitis phenotype and non-exacerbator phenotype in patients with chronic obstructive pulmonary disease: a meta-analysis and system review.
    Wu JJ; Xu HR; Zhang YX; Li YX; Yu HY; Jiang LD; Wang CX; Han M
    BMC Pulm Med; 2020 Apr; 20(1):103. PubMed ID: 32326924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical phenotypes and heath-related quality of life of COPD patients in a rural setting in Malaysia - a cross-sectional study.
    Chai CS; Mos SB; Ng DL; Goh GM; Su AT; Ibrahim MAB; Musa ANB; Tan SB; Pang YK; Liam CK
    BMC Pulm Med; 2020 Sep; 20(1):254. PubMed ID: 32993591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active smoking and COPD phenotype: distribution and impact on prognostic factors.
    Riesco JA; Alcázar B; Trigueros JA; Campuzano A; Pérez J; Lorenzo JL
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1989-1999. PubMed ID: 28740378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Features Of Women With COPD: Sex Differences In A Cross-Sectional Study In Spain ("The ESPIRAL-ES Study").
    Trigueros JA; Riesco JA; Alcázar-Navarrete B; Campuzano A; Pérez J
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2469-2478. PubMed ID: 31806956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
    Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characteristics of the frequent exacerbators with chronic bronchitis phenotype and the asthma-chronic obstructive pulmonary disease overlap syndrome phenotype in chronic obstructive pulmonary disease patients: A meta-analysis and system review.
    Wu JJ; Xu HR; Zhang YX; Li YX; Yu HY; Jiang LD; Wang CX; Han M
    Medicine (Baltimore); 2019 Nov; 98(46):e17996. PubMed ID: 31725666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.
    Montes de Oca M; Aguirre C; Lopez Varela MV; Laucho-Contreras ME; Casas A; Surmont F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3059-3067. PubMed ID: 27994446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality in COPD patients according to clinical phenotypes.
    Golpe R; Suárez-Valor M; Martín-Robles I; Sanjuán-López P; Cano-Jiménez E; Castro-Añón O; Pérez de Llano LA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1433-1439. PubMed ID: 29750029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and characteristics of COPD phenotypes - results from the Polish sub-cohort of the POPE study.
    Kania A; Krenke R; Kuziemski K; Czajkowska-Malinowska M; Celejewska-Wójcik N; Kuźnar-Kamińska B; Farnik M; Bokiej J; Miszczuk M; Damps-Konstańska I; Grabicki M; Trzaska-Sobczak M; Sładek K; Batura-Gabryel H; Barczyk A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1613-1621. PubMed ID: 29844667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery.
    Miravitlles M; Soler-Cataluña JJ; Calle M; Molina J; Almagro P; Quintano JA; Riesco JA; Trigueros JA; Piñera P; Simón A; López-Campos JL; Soriano JB; Ancochea J;
    Arch Bronconeumol; 2012 Jul; 48(7):247-57. PubMed ID: 22561012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Asthma-COPD Overlap, Asthma, and Chronic Obstructive Pulmonary Disease Phenotypes in Patients with Airway Obstruction: Influence on Treatment Approach.
    Romem A; Rokach A; Bohadana A; Babai P; Arish N; Azulai H; Glazer M; Izbicki G
    Respiration; 2020; 99(1):35-42. PubMed ID: 31694032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of physician-diagnosed COPD in relation to spirometric definitions of COPD in a general population aged 50-64 years - the SCAPIS pilot study.
    Torén K; Murgia N; Olin AC; Hedner J; Brandberg J; Rosengren A; Bergström G
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2269-2275. PubMed ID: 28831247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD).
    Izquierdo-Alonso JL; Rodriguez-Gonzálezmoro JM; de Lucas-Ramos P; Unzueta I; Ribera X; Antón E; Martín A
    Respir Med; 2013 May; 107(5):724-31. PubMed ID: 23419828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative computed tomography measurements of emphysema for diagnosing asthma-chronic obstructive pulmonary disease overlap syndrome.
    Xie M; Wang W; Dou S; Cui L; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2016; 11():953-61. PubMed ID: 27226711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome in a patient with COPD?
    Barrecheguren M; Román-Rodríguez M; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1745-52. PubMed ID: 26366067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.